Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▼ −0.3% | ▼ −4.0% | ▼ −27.0% | ▼ −67.3% | ▼ −75.6% | ▼ −97.1% | ▼ −96.4% | ▼ −100.0% |
| Peer average | ▲ +0.7% | ▲ +0.7% | ▼ −6.6% | ▼ −33.2% | ▼ −32.5% | ▼ −79.4% | ▼ −52.3% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
Reported holdings are shown below. A share-of-fund chart is unavailable for this portfolio.
Holdings as of 2026-10-30. Derivatives are shown using their reported instrument names.
| Holding | Instrument | Weight |
|---|---|---|
| SPSIBI SWAP ASSET LEG (SPSIBIMLS) | swap | 65.04% |
| SPSIBI SWAP ASSET LEG (SPSIBIBCS) | swap | 41.82% |
| SPSIBI SWAP ASSET LEG (SPSIBICTS) | swap | 18.27% |
| SPSIBI SWAP ASSET LEG (SPSIBIGSS) | swap | 8.63% |
| SPSIBI SWAP ASSET LEG (SPSIBIJPS) | swap | 2.68% |
| SPSIBI SWAP ASSET LEG (SPSIBIUBS) | swap | 0.84% |
| DREYFUS TRSRY SECURITIES CASH MGMT | Reported holding | -1.62% |
| GOLDMAN SACHS FIN GOV 465 INSTITUT | Reported holding | -3.04% |
| DREYFUS GOVT CASH MAN INS | Reported holding | -11.85% |
| GOLDMAN FINL SQ TRSRY INST 506 | Reported holding | -20.78% |
The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. It's important to note, however, that there is no assurance these funds will successfully achieve their intended daily objectives.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-09-22 | 2026-09-29 | $0.07 |
| 2026-06-23 | 2026-06-30 | $0.08 |
| 2026-03-24 | 2026-03-31 | $0.09 |
| 2025-12-23 | 2025-12-31 | $0.23 |
| 2025-09-23 | 2025-09-30 | $0.26 |
| 2025-06-24 | 2025-07-01 | $0.37 |
| 2025-03-25 | 2025-04-01 | $0.55 |
| 2024-12-23 | 2024-12-31 | $1.26 |
| 2024-09-24 | 2024-10-01 | $0.58 |
| 2024-06-25 | 2024-07-02 | $0.89 |
| 2024-03-19 | 2024-03-26 | $0.66 |
| 2023-12-21 | 2023-12-29 | $0.85 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind LABD.